Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
B 70.46 1.18% 0.82
EXAS closed up 1.18 percent on Wednesday, October 30, 2024, on 52 percent of normal volume.
9 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Earnings Movers Other 0.00%
Multiple of Ten Bullish Other 0.00%
Up 3 Days in a Row Strength 0.00%
Crossed Above 20 DMA Bullish 1.18%
Bollinger Band Squeeze Range Contraction 1.18%
Doji - Bullish? Reversal 1.18%
Multiple of Ten Bearish Other 1.18%
20 DMA Resistance Bearish 1.60%

   Recent Intraday Alerts

Alert Time
Up 3% about 14 hours ago
Up 2% about 16 hours ago
60 Minute Opening Range Breakout about 17 hours ago
Up 1% about 18 hours ago
10 DMA Resistance about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Exact Sciences Corporation Description

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Medical Test Pancreatic Cancer Colorectal Cancer Lab Testing Inflammatory Bowel Disease Polyp Molecular Diagnostics Cancer Screening Genzyme Mayo Clinic

Is EXAS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 79.62
52 Week Low 40.624
Average Volume 2,070,031
200-Day Moving Average 58.83
50-Day Moving Average 66.38
20-Day Moving Average 69.66
10-Day Moving Average 70.03
Average True Range 2.21
RSI (14) 56.71
ADX 16.73
+DI 19.22
-DI 15.05
Chandelier Exit (Long, 3 ATRs) 65.37
Chandelier Exit (Short, 3 ATRs) 72.95
Upper Bollinger Bands 71.99
Lower Bollinger Band 67.33
Percent B (%b) 0.67
BandWidth 6.70
MACD Line 1.03
MACD Signal Line 1.35
MACD Histogram -0.3158
Fundamentals Value
Market Cap 12.74 Billion
Num Shares 181 Million
EPS -1.58
Price-to-Earnings (P/E) Ratio -44.59
Price-to-Sales 4.67
Price-to-Book 3.51
PEG Ratio -1.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 74.01
Resistance 3 (R3) 74.04 72.89 73.42
Resistance 2 (R2) 72.89 71.99 72.88 73.22
Resistance 1 (R1) 71.68 71.43 72.29 71.64 73.02
Pivot Point 70.53 70.53 70.83 70.51 70.53
Support 1 (S1) 69.31 69.62 69.92 69.28 67.90
Support 2 (S2) 68.16 69.07 68.15 67.70
Support 3 (S3) 66.95 68.16 67.50
Support 4 (S4) 66.91